LA
MEDP icon

Legacy Advisors’s Medpace MEDP Stock Holding History

Legacy Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,682
Closed -$1.43M – 248
2025
Q1 		$1.43M Sell
4,682
-72
-2% -$24.2K 0.15% 119
2024
Q4 		$1.58M Buy
4,754
+162
+4% +$54.9K 0.15% 103
2024
Q3 		$1.53M Sell
4,592
-155
-3% -$58.9K 0.17% 105
2024
Q2 		$1.96M Buy
4,747
+59
+1% +$23.4K 0.24% 76
2024
Q1 		$1.89M Buy
4,688
+353
+8% +$124K 0.24% 78
2023
Q4 		$1.33M Buy
4,335
+5
+0.1% +$1.35K 0.17% 104
2023
Q3 		$1.05M Buy
4,330
+219
+5% +$56K 0.17% 118
2023
Q2 		$987K Buy
4,111
+194
+5% +$40.3K 0.15% 117
2023
Q1 		$737K Buy
3,917
+85
+2% +$17.6K 0.14% 119
2022
Q4 		$814K Buy
3,832
+706
+23% +$141K 0.15% 103
2022
Q3 		$491K Buy
3,126
+764
+32% +$122K 0.11% 128
2022
Q2 		$354K Buy
+2,362
New +$342K 0.07% 151

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Legacy Advisors's MEDP Position: Q2 2025 in Review

Legacy Advisors sold out of Medpace (MEDP) in Q2 2025, closing a stake of 4,682 shares — an estimated $1.43M sold.

Legacy Advisors first reported a position in MEDP in Q2 2022 and held it in 12 quarters. The position peaked at $1.96M in Q2 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • Legacy Advisors reported no remaining Medpace position as of Q2 2025 after selling out during the quarter.
  • Legacy Advisors sold 4,682 Medpace shares in Q2 2025, an estimated $1.43M.
  • Legacy Advisors first reported a position in Medpace in Q2 2022 and held it in 12 quarters.
  • Legacy Advisors's Medpace position peaked at $1.96M in Q2 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Legacy Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.